Consistent with these reports, this study also demonstrated that anti-MDA5 antibody and anti-Ro-52 antibody were both specific biomarkers for DM/CADM-associated RP-ILD (8, 32). The gene discussed is TRIM21; the disease is clinically amyopathic dermatomyositis.